[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4979 followers Created: 2025-07-20 18:04:49 UTC 🦉 Dropout rate in women: 18.2%. Main reasons—GI intolerance (9.8%) and lack of follow-up (4.4%). No severe adverse events reported; discontinuation not linked to any baseline factor. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX  XXX engagements  **Related Topics** [sny](/topic/sny) [pfe](/topic/pfe) [manat](/topic/manat) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [Post Link](https://x.com/AponiaAnalytics/status/1946994720879579144)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4979 followers
Created: 2025-07-20 18:04:49 UTC
🦉 Dropout rate in women: 18.2%. Main reasons—GI intolerance (9.8%) and lack of follow-up (4.4%). No severe adverse events reported; discontinuation not linked to any baseline factor.
#GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX
XXX engagements
/post/tweet::1946994720879579144